Prognostic significance of pathological response and lymph node status in neoadjuvant immunotherapy for potentially resectable non-small cell lung cancer
In potentially resectable NSCLC, MPR and CPR demonstrate similar PFS benefits after neoadjuvant immunotherapy. Lymph node status significantly influences prognosis, even in initially unresectable cases. The proposed risk stratification provides a valuable tool for personalized management in this challenging patient population.
Authors
- Hongsheng Liu (ORCID: https://orcid.org/0000-0003-4188-9638)
- Yuan Xu (ORCID: https://orcid.org/0000-0002-2836-5293)
- Yingzhi Qin
- Dongjie Ma
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1080/07853890.2025.2453825
- Citations
- 4
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.07